Ninian Lang

Register here: lnkd.in/exexXAef

Cancer therapies can carry CV risks, but current safety tools fall short. The Cardiac Safety Research Consortium led a multi-stakeholder think tank to improve CV safety reporting in oncology trials. Read the findings + next steps in #JACCCardioOnc: jacc.org/doi/10.1016/j.…

Have you got a history of heart disease and/or cancer? Or are you the relative of someone who has? Our CardioOncology research group is gathering the public's opinion on what our priorities should be! ✅ only takes 15mins ✅ completely confidential forms.office.com/e/khM0e5w48g

Learn about the practical guide to cardiotoxicity risk stratification, straight from the #ESC guidelines. #ESCardioOnco Join the webinar🔗: myesc.escardio.org/MyESC/s/event-…

Professor @markcpetrie20 takes us through detecting the aetiology of heart failure 🫀 need to do more digging rather than label of HFpEF or HFrEF 🫀 be comprehensive - genetics, drugs 🫀 Inflammatory cardiomyopathies are more common than you think!

If you treat lung cancer & have queries about radiation heart disease then check out this new @WashUMedRadOnc paper! 100 years on from its 1st description we summarise what is known (and not known) & highlight priorities for the field to maximise patient benefit

Thoracic RadOncs should check out our paper in this month's Clinical Oncology pubmed.ncbi.nlm.nih.gov/39317606/ We worked with the International Cardio-Oncology Society to develop a survey for stock-taking practice in lung cancer radiotherapy & to identify key gaps & solutions

#JACCCardioOnc EiC Dr. Bonnie Ky @PennThalheimer on next steps regarding SARAH trial, #AHA24: 🔹Advance precision medicine 🔹Identify high-risk populations who benefit from cardioprotection 🔹Develop rigorous consensus definitions of clinically relevant endpoints 🔹Define impact on longer term clinical outcomes 📎: jacc.org/doi/abs/10.101… #CardioOnc

👀 #ImpactFactor for @JACCJournals #JACC:CardioOncology has been recalculated for 2023 — up to 13.6! 😮 Ranks #8/222 Cardiology journals (and 18/322 Oncology journals) in the 🌎. Meteoric rise & a testament to the amazing #BonnieKy and an incredible #CardioOnc community. @PennThalheimer @ArmenianSaro @ninianlang @dineshpmcc1 @DarrylLeong @carmenbergom @gmelendezMD @p_van_der_meer @yurikim_mdphd @ericchowmd @SWaliany @Richardkcheng2 @anguyen4194 @HanZhuMD

Only 5 weeks to go to the booking deadline for the @BritishCardioSo @BCOSCardioOnc @uclh Cancer Academy Cardio-Oncology Course - a fantastic range of speakers, sessions for oncologists and haematologists. 🗓️Monday 11 November 2024 📍 @RCPhysicians tinyurl.com/3tdy2z7u

This will inform future discussions and funding applications for collaborative UK cardio-oncology research. For further information, please contact enquiries@bhfcrc.org.

Please take 10 minutes to complete this short survey (forms.office.com/e/sA3Mzeev3D), which seeks to gain an overview of opinions from UK-based healthcare professionals in relation to cardio-oncology research priorities.

Do you have a specialist interest in cardio-oncology & would like to help inform future research priorities? The NIHR-BHF Cardiovascular Partnership theme in Cardio-Oncology is keen to hear from you to help facilitate future study design & maximise collaboration across the UK.

This joint @BritishCardioSo @BCOSCardioOnc and @UCLH Cancer Academy course will give the attendee an update in contemporary cardio-oncology practice and will cover recent updates in cardio-oncology. …s.britishcardiovascularsociety.org.uk/events/668d45d…

We are highlighting the sessions you can expect at BSEcho 2024 - we're excited to see you in Edinburgh! See the programme for our cardio-oncology session in association with @BCOSCardioOnc 👇 View the full programme and book on our website: ow.ly/PFpC50SZ6rA

The PROACT trial found adding enalapril to standard care during chemotherapy did not prevent cardiotoxicity in patients receiving high-dose anthracycline-based chemotherapy. Read more on the trial: bit.ly/3ZnZWiV #ACCLATAM

Much of great science starts with a poster. #ESCCongress2024 had a phenomenal #Cardioonc line-up, hard to cover it all! Great homework x Editors 😉@JACCJournals @ESC_Journals @AHAScience Kudos to ALL presenters&mentors & @escardio! @TeresaLpezFdez1

Don’t miss an opportunity to join #JACCCardioOnc Editor-in-Chief Bonnie Ky, MD, MSCE, FACC, to discuss manuscript ideas, works in progress and new ideas during #ESCCongress 2024! Walk in and take advantage of 1:1 discussion time with bi-directional feedback on your work. Learn More: bit.ly/3X2sQ5A

Wow!!! 🤯 New #ImpactFactor release and another record for @JACCJournals JACC: CardioOncology! < 5 years old and already the #9 Cardiology journal in the 🌎 and #2 #JACC subjournal. Amazing leadership from #BonnieKy! 🙂 @ArmenianSaro @ninianlang @dineshpmcc1 @PennThalheimer